|
|
|
(Aug. 15, 2025) – We encourage you to register and join us for the 2025 KHA Annual Convention and Trade Show, where nearly 175 professional exhibitors will showcase state-of-the-art products and services.
|
|
|
|
|
|
(Aug. 15, 2025) – On Monday, Aug. 11, KDHE submitted the response to the latest round of questions on the 2025 provider assessment preprint to CMS.
|
|
|
|
|
|
(Aug. 15, 2025) – This day-and-a-half-long session, on Sept. 18 and 19 in Wichita, is an initiative developed with the guidance of KHA’s Hospital Physician Leadership Committee in partnership with the Kansas Leadership Center.
|
|
|
|
|
|
(Aug. 15, 2025) – There's still time for administrative professionals and executive assistants to register for the next KHA Administrative Professional Networking Roundtable Zoom Meeting from 10:30 a.m. to 11:30 a.m. on Wednesday, Sept. 17.
|
|
|
|
|
|
(Aug. 15, 2025) – Bridge to Care includes three toolkits for transitioning patients with opioid use disorder and stimulant use disorder across the inpatient, primary care and pharmacy settings.
|
|
|
|
|
|
(Aug. 15, 2025) – KSHIMSS invites those attending the KHA Annual Convention to attend their luncheon and educational session, AI – What We Think We Know.
|
|
|
|
|
|
(Aug. 15, 2025) – KAHPAM is pleased to announce the 2025 KAHPAM Fall Workshop at the Hilton Garden Inn & Convention Center in Salina. This workshop will be in-person and include presentations from CorroHealth, Pinnacle Healthcare Advisors, KHA, as well as a roundtable discussion.
|
|
|
|
|
|
(Aug. 15, 2025) – Our partners at the Kansas City Regional Fusion Center shared, 'Purple' Fentanyl Found in Omaha, from the Omaha Police Department about a new type of street drug referred to as "purple" fentanyl.
|
|
|
|
|
|
(Aug. 15, 2025) – The AHRQ Safety Program for Healthcare-Associated Infection is now recruiting hospitals for its next CAUTI cohort. Eligible hospitals must have adult ICUs and non-ICUs, at least 50 total beds and five beds per unit.
|
|
|
|
|
|
(Aug. 15, 2025) – Last week, the FDA announced the agency is requiring safety labeling changes for all opioid pain medications.
|
|
|